Lee Chan Joo, Lee Hokyou, Yoon Minjae, Chun Kyeong-Hyeon, Kong Min Gyu, Jung Mi-Hyang, Kim In-Cheol, Cho Jae Yeong, Kang Jeehoon, Park Jin Joo, Kim Hyeon Chang, Choi Dong-Ju, Lee Jungkuk, Kang Seok-Min
Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea.
Int J Heart Fail. 2024 Apr 18;6(2):56-69. doi: 10.36628/ijhf.2024.0010. eCollection 2024 Apr.
The number of people with heart failure (HF) is increasing worldwide, and the social burden is increasing as HF has high mortality and morbidity. We aimed to provide updated trends on the epidemiology of HF in Korea to shape future social measures against HF.
We used the National Health Information Database of the National Health Insurance Service to determine the prevalence, incidence, hospitalization rate, mortality rate, comorbidities, in-hospital mortality, and healthcare cost of patients with HF from 2002 to 2020 in Korea.
The prevalence of HF in the total Korean population rose from 0.77% in 2002 to 2.58% (1,326,886 people) in 2020. Although the age-standardized incidence of HF decreased over the past 18 years, the age-standardized prevalence increased. In 2020, the hospitalization rate for any cause in patients with HF was 1,166 per 100,000 persons, with a steady increase from 2002. In 2002, the HF mortality was 3.0 per 100,000 persons, which rose to 15.6 per 100,000 persons in 2020. While hospitalization rates and in-hospital mortality for patients with HF increased, the mortality rate for patients with HF did not (5.8% in 2020), and the one-year survival rate from the first diagnosis of HF improved. The total healthcare costs for patients with HF were approximately $2.4 billion in 2020, a 16-fold increase over the $0.15 billion in 2002.
The study's results underscore the growing socioeconomic burden of HF in Korea, driven by an aging population and increasing HF prevalence.
全球心力衰竭（HF）患者数量不断增加，由于HF具有高死亡率和高发病率，社会负担也日益加重。我们旨在提供韩国HF流行病学的最新趋势，以制定未来针对HF的社会措施。
我们使用了国民健康保险服务的国家健康信息数据库，来确定2002年至2020年韩国HF患者的患病率、发病率、住院率、死亡率、合并症、院内死亡率和医疗费用。
韩国总人口中HF的患病率从2002年的0.77%上升至2020年的2.58%（1326886人）。尽管过去18年HF的年龄标准化发病率有所下降，但年龄标准化患病率却有所上升。2020年，HF患者因任何原因的住院率为每10万人1166例，自2002年以来稳步上升。2002年，HF死亡率为每10万人3.0例，2020年升至每10万人15.6例。虽然HF患者的住院率和院内死亡率有所上升，但HF患者的死亡率并未上升（2020年为5.8%），且首次诊断HF后的一年生存率有所提高。2020年HF患者的总医疗费用约为24亿美元，是2002年1.5亿美元的16倍。
研究结果强调了在韩国，受人口老龄化和HF患病率上升的推动，HF的社会经济负担日益加重。
